Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseLeasesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Orchestra BioMed Holdings (OBIO) Leases (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Leases for 4 consecutive years, with $1.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Leases fell 3.56% to $1.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.7 million, a 3.56% decrease, with the full-year FY2024 number at $2.1 million, up 35.24% from a year prior.
  • Leases was $1.7 million for Q3 2025 at Orchestra BioMed Holdings, down from $1.8 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $2.2 million in Q4 2022 to a low of $1.3 million in Q2 2024.
  • A 4-year average of $1.8 million and a median of $1.8 million in 2023 define the central range for Leases.
  • Peak YoY movement for Leases: dropped 28.98% in 2024, then soared 35.69% in 2025.
  • Orchestra BioMed Holdings' Leases stood at $2.2 million in 2022, then decreased by 28.9% to $1.6 million in 2023, then skyrocketed by 35.24% to $2.1 million in 2024, then fell by 21.4% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for OBIO's Leases are $1.7 million (Q3 2025), $1.8 million (Q2 2025), and $2.0 million (Q1 2025).